Trial Profile
Interstitial Photodynamic Therapy During Standard Chemotherapy for Palliation of Patients With Head and Neck Squamous Cell Carcinoma - Phase II
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Head and neck cancer; Orofacial cancer; Oropharyngeal cancer
- Focus Therapeutic Use
- 20 Oct 2016 Status changed from recruiting to discontinued.
- 02 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 17 Mar 2014 New trial record